股本结构
单位：万股
| 公告日期 | 2024-05-15 | 2024-05-15 | 2024-03-21 | 2024-03-21 | 2023-11-03 | 2023-11-03 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1225.45 | 1135.05 | 1096.25 | 1039.66 | 1039.36 | 1021.49 |
| 普通股本 | 1225.45 | 1135.05 | 1096.25 | 1039.66 | 1039.36 | 1021.49 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-05-13 | 2024-03-31 | 2024-03-18 | 2023-12-31 | 2023-10-31 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-05-15 | 1225.45 | 未披露 | 定期报告 | 2024-05-13 |
| 2024-05-15 | 1135.05 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
|
2024-03-31 |
| 2024-03-21 | 1096.25 | 未披露 | 定期报告 | 2024-03-18 |
| 2024-03-21 | 1039.66 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
Issuance of common stock and pre-funded warrants
Issuance of common stock upon vesting of RSUs
|
2023-12-31 |
| 2023-11-03 | 1039.36 | 未披露 | 定期报告 | 2023-10-31 |
| 2023-10-05 | 1032.49 | 未披露 |
更多>>
Securities offered 110,000 shares by the company
|
2023-10-05 |
| 2023-10-05 | 1021.49 | 未披露 | 定期报告 | 2023-10-02 |
| 2023-11-03 | 1021.49 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
|
2023-09-30 |
| 2023-08-11 | 976.91 | 未披露 | 定期报告 | 2023-08-09 |
| 2023-10-05 | 973.25 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock
Issuance of common stock upon vesting of RSUs
Issuance of common stock upon exercise of warrants
|
2023-06-30 |
| 2023-06-01 | 949.12 | 未披露 | 定期报告 | 2023-05-30 |
| 2023-05-11 | 949.03 | 未披露 | 定期报告 | 2023-05-09 |
| 2023-04-21 | 944.94 | 未披露 |
更多>>
Common Stock offered 948,000 shares by the company
|
2023-04-24 |
| 2023-04-28 | 854.23 | 未披露 | 定期报告 | 2023-04-17 |
| 2023-06-01 | 853.10 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock upon exercise of warrants
Issuance of common stock
Issuance of common stock upon vesting of RSUs
Issuance of common stock for services
|
2023-03-31 |
| 2023-03-31 | 850.14 | 未披露 | 定期报告 | 2023-03-28 |
| 2023-01-30 | 831.78 | 未披露 | 定期报告 | 2023-01-13 |
| 2023-03-31 | 831.80 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock
Issuance of common stock upon extinguishment of notes payable and accrued interest
Issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of warrants
Issuance of common stock in connection with the Merger
Issuance of common stock in connection with Private Placement, net of transaction costs
|
2022-12-31 |
| 2022-12-16 | 155.09 | 未披露 |
更多>>
1:7 reverse stock split
|
2022-12-19 |
| 2022-11-14 | 1085.65 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units
Forfeiture of restricted stock awards
|
2022-09-30 |
| 2022-08-04 | 1085.65 | 未披露 | 定期报告 | 2022-07-28 |
| 2022-08-04 | 1084.29 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Forfeiture of restricted stock awards
|
2022-06-30 |
| 2022-05-12 | 1084.29 | 未披露 | 定期报告 | 2022-05-05 |
| 2022-05-12 | 1084.67 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock from at the market offering
Vesting of restricted stock units
Forfeiture of restricted stock awards
|
2022-03-31 |
| 2022-03-24 | 1082.97 | 未披露 | 定期报告 | 2022-03-17 |
| 2022-03-24 | 1064.47 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock from at the market offering, net of issuance costs of $44
Exercises of common stock options
Vesting of restricted stock units
Issuance of restricted stock awards
|
2021-12-31 |
| 2021-11-15 | 1030.84 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercises of common stock options
Vesting of restricted stock units
|
2021-09-30 |
| 2021-08-12 | 1030.63 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-12 | 1028.20 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock from at the market offering, net of issuance costs
Exercises of common stock options
|
2021-06-30 |
| 2021-05-13 | 1020.25 | 未披露 | 定期报告 | 2021-05-07 |
| 2021-03-31 | 1019.38 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of Class C preferred units, net of issuance costs of $388
Exchange of Ordinary Class B preferred units for Defaulting Class B Preferred units
Exchange of preferred units of Yumanity Holdings, LLC for shares of common stock of Yumanity Therapeutics, Inc., adjusted to reflect the Exchange Ratio
Forfeiture of unvested incentive units
Exchange of common units of Yumanity Holdings, LLC for shares of common stock of Yumanity Therapeutics, Inc., adjusted to reflect the Exchange Ratio
Exchange of common stock in connection with the Merger
Private placement of common stock, net of issuance costs of $1,996
|
2020-12-31 |
| 2020-12-22 | 260.92 | 未披露 |
更多>>
Proteostasis' Board of Directors has determined to effect a reverse stock split of the Proteostasis common stock at a ratio of 1-for-20. The reverse stock split is expected to become effective at 12:00 p.m. Eastern Time on December 22, 2020.
|
2020-12-23 |
| 2020-11-16 | 5218.48 | 未披露 | 定期报告 | 2020-11-12 |
| 2020-10-28 | 5218.04 | 未披露 | 定期报告 | 2020-08-20 |
| 2020-08-06 | 5217.59 | 未披露 | 定期报告 | 2020-08-03 |
| 2020-05-15 | 5214.77 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock pursuant to employee stock purchase plan
|
2020-03-31 |
| 2020-03-10 | 5214.77 | 未披露 | 定期报告 | 2020-03-06 |
| 2020-03-10 | 5211.66 | 未披露 |
更多>>
from December 31,2018 to December 31, 2019
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock for payment of consulting services
Vesting of restricted stock units
Issuance of common stock related to at-the-market offering program, net
|
2019-12-31 |
| 2019-11-07 | 5112.90 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Issuance of common stock pursuant to employee stock purchase plan
|
2019-09-30 |
| 2019-08-07 | 5112.90 | 未披露 | 定期报告 | 2019-08-05 |
| 2019-08-07 | 5109.93 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Issuance of common stock for payment of consulting services
|
2019-06-30 |
| 2019-04-30 | 5109.93 | 未披露 | 定期报告 | 2019-04-12 |
| 2019-05-08 | 5104.32 | 未披露 |
更多>>
from December 31,2018 to March 31, 2019
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock for payment of consulting services
Vesting of restricted stock units
|
2019-03-31 |
| 2019-03-08 | 5104.06 | 未披露 | 定期报告 | 2019-02-28 |
| 2019-03-08 | 5080.84 | 未披露 |
更多>>
from December 31,2017 to December 31,2018
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock for payment of consulting services
Issuance of common stock upon completion of follow-on offering,including overallotment, net
|
2018-12-31 |
| 2018-11-06 | 4915.84 | 未披露 | 定期报告 | 2018-11-02 |
| 2018-11-06 | 3669.69 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-08 | 3669.69 | 未披露 | 定期报告 | 2018-08-03 |
| 2018-08-08 | 3663.59 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-09 | 3608.10 | 未披露 | 定期报告 | 2018-05-07 |
| 2018-04-19 | 3481.28 | 未披露 | 定期报告 | 2018-04-13 |
| 2018-05-09 | 3448.26 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-14 | 3448.26 | 未披露 | 定期报告 | 2018-03-12 |
| 2018-03-14 | 3441.61 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock upon exercise of common stock warrant
Issuance of common stock for payment of consulting services
Issuance of common stock upon completion of follow-on offering including overallotment, net of offering costs
|
2017-12-31 |
| 2017-11-14 | 2521.61 | 未披露 | 定期报告 | 2017-11-09 |
| 2017-11-14 | 2511.27 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-04 | 2510.19 | 未披露 | 定期报告 | 2017-08-01 |
| 2017-08-04 | 2504.93 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-06-07 | 2504.48 | 未披露 | 定期报告 | 2017-06-02 |
| 2017-05-12 | 2504.15 | 未披露 | 定期报告 | 2017-05-09 |
| 2017-05-12 | 2502.40 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-30 | 2502.40 | 未披露 | 定期报告 | 2017-03-21 |
| 2017-03-30 | 2500.07 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Conversion of convertible preferred stock to common stock
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
Issuance of common stock upon completion of follow-on offering including overallotment, net of offering costs
Issuance of common stock for payment of consulting services
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
|
2016-12-31 |
| 2016-11-10 | 2496.02 | 未披露 | 定期报告 | 2016-11-08 |
| 2016-11-10 | 2494.51 | 未披露 |
更多>>
From December 31, 2015 to September 30, 2016
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Conversion of convertible preferred stock to common stock
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
Issuance of common stock upon completion of follow-on offering including overallotment, net of offering costs
Issuance of common stock for payment of consulting services
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
|
2016-09-30 |
| 2016-08-15 | 1918.30 | 未披露 | 定期报告 | 2016-08-09 |
| 2016-08-15 | 1913.95 | 未披露 |
更多>>
from December 31, 2015 to June 30, 2016
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Conversion of convertible preferred stock to common stock
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
On January 19, 2016, the Company effected a 1-for-10.8102 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company’s Preferred Stock.
|
2016-06-30 |
| 2016-05-13 | 1913.95 | 未披露 | 定期报告 | 2016-05-12 |
| 2016-05-13 | 1913.90 | 未披露 |
更多>>
from December 31, 2015 to March 31, 2016
Conversion of convertible preferred stock to common stock
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
|
2016-03-31 |
| 2016-03-30 | 1913.90 | 未披露 | 定期报告 | 2016-03-30 |
| 2016-02-12 | 1911.15 | 未披露 |
更多>>
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
|
2016-02-11 |
| 2016-03-30 | 57.11 | 10485.48 |
更多>>
From December 31, 2014 to December 31, 2015
Issuance of Series B convertible preferred stock, net of issuance costs of $910
Conversion of convertible promissory notes and accrued interest into Series B convertible preferred stock
Exercise of stock options
|
2015-12-31 |
| 2016-02-01 | 56.19 | 10485.48 |
更多>>
from December 31, 2014 to September 30, 2015
Issuance of Series B convertible preferred stock, net of issuance costs of $910
Conversion of convertible promissory notes and accrued interest into Series B convertible preferred stock
Exercise of stock options
|
2015-09-30 |
From December 31, 2023 to March 31, 2024
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
From December 31, 2022 to December 31, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
Issuance of common stock and pre-funded warrants
Issuance of common stock upon vesting of RSUs
Securities offered 110,000 shares by the company
From June 30, 2023 to September 30, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
From March 31, 2023 to June 30, 2023
Issuance of common stock
Issuance of common stock upon vesting of RSUs
Issuance of common stock upon exercise of warrants
Common Stock offered 948,000 shares by the company
From December 31, 2022 to March 31, 2023
Issuance of common stock upon exercise of warrants
Issuance of common stock
Issuance of common stock upon vesting of RSUs
Issuance of common stock for services
From December 31, 2021 to December 31, 2022
Issuance of common stock
Issuance of common stock upon extinguishment of notes payable and accrued interest
Issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of warrants
Issuance of common stock in connection with the Merger
Issuance of common stock in connection with Private Placement, net of transaction costs
1:7 reverse stock split
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units
Forfeiture of restricted stock awards
From March 31, 2022 to June 30, 2022
Forfeiture of restricted stock awards
From December 31, 2021 to March 31, 2022
Issuance of common stock from at the market offering
Vesting of restricted stock units
Forfeiture of restricted stock awards
From December 31, 2020 to December 31, 2021
Issuance of common stock from at the market offering, net of issuance costs of $44
Exercises of common stock options
Vesting of restricted stock units
Issuance of restricted stock awards
From June 30, 2021 to September 30, 2021
Exercises of common stock options
Vesting of restricted stock units
From March 31, 2021 to June 30, 2021
Issuance of common stock from at the market offering, net of issuance costs
Exercises of common stock options
From December 31, 2019 to December 31, 2020
Issuance of Class C preferred units, net of issuance costs of $388
Exchange of Ordinary Class B preferred units for Defaulting Class B Preferred units
Exchange of preferred units of Yumanity Holdings, LLC for shares of common stock of Yumanity Therapeutics, Inc., adjusted to reflect the Exchange Ratio
Forfeiture of unvested incentive units
Exchange of common units of Yumanity Holdings, LLC for shares of common stock of Yumanity Therapeutics, Inc., adjusted to reflect the Exchange Ratio
Exchange of common stock in connection with the Merger
Private placement of common stock, net of issuance costs of $1,996
Proteostasis' Board of Directors has determined to effect a reverse stock split of the Proteostasis common stock at a ratio of 1-for-20. The reverse stock split is expected to become effective at 12:00 p.m. Eastern Time on December 22, 2020.
From December 31, 2019 to March 31, 2020
Issuance of common stock pursuant to employee stock purchase plan
from December 31,2018 to December 31, 2019
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock for payment of consulting services
Vesting of restricted stock units
Issuance of common stock related to at-the-market offering program, net
From June 30, 2019 to September 30, 2019
Issuance of common stock pursuant to employee stock purchase plan
from March 31, 2019 to June 30,2019
Issuance of common stock for payment of consulting services
from December 31,2018 to March 31, 2019
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock for payment of consulting services
Vesting of restricted stock units
from December 31,2017 to December 31,2018
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock for payment of consulting services
Issuance of common stock upon completion of follow-on offering,including overallotment, net
from December 31, 2016 to December 31, 2017
Exercise of stock options
Issuance of common stock pursuant to employee stock purchase plan
Issuance of common stock upon exercise of common stock warrant
Issuance of common stock for payment of consulting services
Issuance of common stock upon completion of follow-on offering including overallotment, net of offering costs
From December 31, 2015 to December 31, 2016
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Conversion of convertible preferred stock to common stock
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
Issuance of common stock upon completion of follow-on offering including overallotment, net of offering costs
Issuance of common stock for payment of consulting services
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
From December 31, 2015 to September 30, 2016
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Conversion of convertible preferred stock to common stock
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
Issuance of common stock upon completion of follow-on offering including overallotment, net of offering costs
Issuance of common stock for payment of consulting services
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
from December 31, 2015 to June 30, 2016
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Conversion of convertible preferred stock to common stock
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
On January 19, 2016, the Company effected a 1-for-10.8102 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company’s Preferred Stock.
from December 31, 2015 to March 31, 2016
Conversion of convertible preferred stock to common stock
Exercise of stock options
Issuance of common stock upon completion of initial public offering, net of offering costs
Issuance of common stock to settle accruing Series A dividends
Issuance of common stock for partial payment of accrued bonus
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
Gives effect to the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 9,699,600 shares of our common stock;Gives effect to the issuance of 2,590,742 shares of common stock upon the closing of this offering as payment of $36.0 million of accruing dividends due, as of November 30, 2015, to the holders of Series A preferred stock upon conversion of such shares;Reflects a one-for-10.8102 reverse stock split of our common stock effected on January 19, 2016.
From December 31, 2014 to December 31, 2015
Issuance of Series B convertible preferred stock, net of issuance costs of $910
Conversion of convertible promissory notes and accrued interest into Series B convertible preferred stock
Exercise of stock options
from December 31, 2014 to September 30, 2015
Issuance of Series B convertible preferred stock, net of issuance costs of $910
Conversion of convertible promissory notes and accrued interest into Series B convertible preferred stock
Exercise of stock options